AGH Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$778K Buy
846
+31
+4% +$31.4K 0.57% 38
2025
Q4
$876K Sell
815
-87
-10% -$83.2K 0.66% 30
2025
Q3
$688K Sell
902
-223
-20% -$166K 0.5% 37
2025
Q2
$877K Buy
1,125
+42
+4% +$32.6K 0.72% 25
2025
Q1
$894K Buy
1,083
+35
+3% +$29.1K 0.86% 26
2024
Q4
$809K Buy
+1,048
New +$868K 0.75% 29

Other funds holding LLY

AGH Wealth Advisors's LLY Position: Q1 2026 in Review

AGH Wealth Advisors increased its Eli Lilly (LLY) stake by 3.8% in Q1 2026, buying an estimated $31.4K and bringing the position to 846 shares worth $778K. The position accounts for 0.57% of the portfolio, ranked #38.

AGH Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $894K in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • AGH Wealth Advisors held 846 shares of Eli Lilly worth $778K as of Q1 2026.
  • AGH Wealth Advisors bought 31 Eli Lilly shares in Q1 2026, an estimated $31.4K.
  • Eli Lilly made up 0.57% of AGH Wealth Advisors's portfolio in Q1 2026, its #38 holding.
  • AGH Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • AGH Wealth Advisors's Eli Lilly position peaked at $894K in Q1 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on AGH Wealth Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.